These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20443909)

  • 1. Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?
    Yancy CW; Feldman A
    Clin Transl Sci; 2009 Aug; 2(4):309-11. PubMed ID: 20443909
    [No Abstract]   [Full Text] [Related]  

  • 2. Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
    Ferdinand KC
    J Law Med Ethics; 2008; 36(3):458-63. PubMed ID: 18840236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Flack JM
    Expert Opin Pharmacother; 2007 Feb; 8(3):275-7. PubMed ID: 17266462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
    Ofili E; Anand I; Williams RA; Akinboboye O; Xu L; Puckrein G
    Adv Ther; 2017 Aug; 34(8):1976-1988. PubMed ID: 28707284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug targeting: is race enough?
    Wadman M
    Nature; 2005 Jun; 435(7045):1008-9. PubMed ID: 15973367
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
    Anand IS; Win S; Rector TS; Cohn JN; Taylor AL
    Circ Heart Fail; 2014 Sep; 7(5):759-65. PubMed ID: 24970468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
    Colvin-Adams M; Taylor AL
    Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
    Yancy CW; Ghali JK; Braman VM; Sabolinski ML; Worcel M; Archambault WT; Franciosa JA
    Am J Cardiol; 2007 Aug; 100(4):684-9. PubMed ID: 17697829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U; Bitar F
    Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure.
    Echols MR; Yancy CW
    Vasc Health Risk Manag; 2006; 2(4):423-31. PubMed ID: 17323596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
    Ferdinand KC; Elkayam U; Mancini D; Ofili E; Piña I; Anand I; Feldman AM; McNamara D; Leggett C
    Am J Cardiol; 2014 Jul; 114(1):151-9. PubMed ID: 24846808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
    N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure.
    Franciosa JA
    Expert Opin Pharmacother; 2006 Dec; 7(18):2521-31. PubMed ID: 17150006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
    Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
    J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
    Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
    N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
    Brewster LM
    ESC Heart Fail; 2019 Jun; 6(3):487-498. PubMed ID: 30892835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BiDil flops.
    Huggett B
    Nat Biotechnol; 2008 Mar; 26(3):252. PubMed ID: 18327217
    [No Abstract]   [Full Text] [Related]  

  • 18. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
    Taylor AL; Ziesche S; Yancy CW; Carson P; Ferdinand K; Taylor M; Adams K; Olukotun AY; Ofili E; Tam SW; Sabolinski ML; Worcel M; Cohn JN;
    Circulation; 2007 Apr; 115(13):1747-53. PubMed ID: 17372175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F.D.A. approves a heart drug for African-Americans.
    Saul S
    N Y Times Web; 2005 Jun; ():C2. PubMed ID: 15981400
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to the February 2006 Journal of Cardiac Failure Editor's comment.
    Puckrein G
    J Card Fail; 2006 Aug; 12(6):487-8. PubMed ID: 16911917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.